Potent Ruthenium–Ferrocene Bimetallic Antitumor Antiangiogenic Agent That Circumvents Platinum Resistance: From Synthesis and Mechanistic Studies to <i>In Vivo</i> Evaluation in Zebrafish-Reference-Cited by-同舟云学术

Potent Ruthenium–Ferrocene Bimetallic Antitumor Antiangiogenic Agent That Circumvents Platinum Resistance: From Synthesis and Mechanistic Studies to In Vivo Evaluation in Zebrafish

Published:2022-12-02 Issue:24 Volume:65 Page:16353-16371
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

M Manikandan¹,Gadre Shubhankar¹,Chhatar Sushanta¹,Chakraborty Gourav²,Ahmed Naushad³^ORCID,Patra Chinmoy²,Patra Malay¹^ORCID

Affiliation:

1. Medicinal Chemistry and Cell Biology Laboratory, Department of Chemical Sciences, Tata Institute of Fundamental Research, Homi Bhabha Road, Mumbai, Maharashtra 400005, India

2. Department of Developmental Biology, Agharkar Research Institute, G G Agarkar Road, Pune, Maharashtra 411004, India

3. Department of Chemistry, Indian Institute of Technology Hyderabad, Kandi, Sangareddy, Telangana 502085, India

Funder

The Wellcome Trust DBT India Alliance

Department of Atomic Energy, Government of India

Tata Institute of Fundamental Research

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.2c01174